Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25-35) oligomer-induced toxicity

Neuroscience Letters

Volumn 473, Issue 2, 2010, Pages 72-76

  Tarozzi, Andrea ^a   Morroni, Fabiana ^a   Merlicco, Adriana ^a   Bolondi, Cecilia ^a   Teti, Gabriella ^a   Falconi, Mirella ^a   Cantelli Forti, Giorgio ^a   Hrelia, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Amyloid beta; Cyanidin 3 O glucopyranoside; Neuroprotection; Oligomers; Plasma membrane damage; Redox status impairment

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CYANIDIN 3 O GLUCOPYRANOSIDE; NEUROPROTECTIVE AGENT; OLIGOMER; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING KINETICS; BRAIN NERVE CELL; CELL MEMBRANE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; ANTHOCYANINS; BIOPOLYMERS; CELL DEATH; CELL LINE; CELL MEMBRANE; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS;

EID: 77949914396     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.02.006     Document Type: Article

References (22)

1. Andres-Lacueva C., Shukitt-Hale B., Galli R.L., Jauregui O., Lamuela-Raventos R.M., Joseph J.A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr. Neurosci. 2005, 8:111-120.
2. Clementi M.E., Marini S., Coletta M., Orsini F., Giardina B., Misiti F. Abeta(31-35) and Abeta(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: role of the redox state of methionine-35. FEBS Lett. 2005, 579:2913-2918.
3. Datki Z., Papp R., Zádori D., Soós K., Fülöp L., Juhász A., Laskay G., Hetényi C., Mihalik E., Zarándi M., Penke B. In vitro model of neurotoxicity of Abeta 1-42 and neuroprotection by a pentapeptide: irreversible events during the first hour. Neurobiol. Dis. 2004, 17:507-515.
4. Findeis M.A. The role of amyloid beta peptide 42 in Alzheimer's disease. Pharmacol. Ther. 2007, 116:266-286.
5. Glabe C.G. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging 2006, 27:570-575.
6. Gowing E., Roher A.E., Woods A.S., Cotter R.J., Chaney M., Little S.P., Ball M.J. Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J. Biol. Chem. 1994, 269:10987-10990.
7. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell. Biol. 2007, 8:101-112.
8. Hong H.S., Maezawa I., Yao N., Xu B., Diaz-Avalos R., Rana S., Hua D.H., Cheng R.H., Lam K.S., Jin L.W. Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicity. Brain Res. 2007, 1130:223-234.
9. Joseph J., Cole G., Head E., Ingram D. Nutrition, brain aging, and neurodegeneration. J. Neurosci. 2009, 29:12795-12801.
10. Kubo T., Nishimura S., Kumagae Y., Kaneko I. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. J. Neurosci. Res. 2002, 70:474-483.
11. LaFerla F.M., Green K.N., Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 2007, 8:499-509.
12. Liu Y., Dargusch R., Banh C., Miller C.A., Schubert D. Detecting bioactive amyloid beta peptide species in Alzheimer's disease. J. Neurochem. 2004, 91:648-656.
13. Liu R., McAllister C., Lyubchenko Y., Sierks M.R. Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation. J. Neurosci. Res. 2004, 75:162-171.
14. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
15. Maezawa I., Hong H.S., Liu R., Wu C.Y., Cheng R.H., Kung M.P., Kung H.F., Lam K.S., Oddo S., Laferla F.M., Jin L.W. Congo red and thioflavin-T analogs detect Abeta oligomers. J. Neurochem. 2008, 104:457-468.
16. Oteiza P.I., Erlejman A.G., Verstraeten S.V., Keen C.L., Fraga C.G. Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface?. Clin. Dev. Immunol. 2005, 12:19-25.
17. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., Cotman C.W. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J. Neurochem. 1995, 64:253-265.
18. Rauk A. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?. Dalton Trans. 2008, 14:1273-1282.
19. Shin W.H., Park S.J., Kim E.J. Protective effect of anthocyanins in middle cerebral artery occlusion and reperfusion model of cerebral ischemia in rats. Life Sci. 2006, 79:130-137.
20. Tarozzi A., Merlicco A., Morroni F., Franco F., Cantelli-Forti G., Teti G., Falconi M., Hrelia P. Cyanidin 3-O-glucopyranoside protects and rescues SH-SY5Y cells against amyloid-beta peptide-induced toxicity. Neuroreport 2008, 19:1483-1486.
21. Tarozzi A., Morroni F., Hrelia S., Angeloni C., Marchesi A., Cantelli-Forti G., Hrelia P. Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells. Neurosci. Lett. 2007, 424:36-40.
22. Townsend M., Cleary J.P., Mehta T., Hofmeister J., Lesne S., O'Hare E., Walsh D.M., Selkoe D.J. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Ann. Neurol. 2006, 60:668-676.